BusinessEisai Registers its First Products in South Africa Posted onNovember 10, 2019February 5, 2020Eisai announces the expansion of its operations in South Africa with the registration of two products (Halaven® (eribulin) for metastatic breast cancer and Fycompa® (perampanel) …